Hemorrhagic Proctocolitis Latest Advances

Find the Latest Research About Hemorrhagic Proctocolitis

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57791 publications

Prenatal Exposure to Acid-Suppressive Medications and Incident Risk of Inflammatory Bowel Disease in Children.

Prenatal Exposure to Acid-Suppressive Medications and Incident Risk of Inflammatory Bowel Disease in Children.

Journal: JAMA network open
Published: June 24, 2026

Physcion-Loaded, Folic Acid-Conjugated DSPE-PEG Liposomes for Targeted Therapy of Ulcerative Colitis.

Physcion-Loaded, Folic Acid-Conjugated DSPE-PEG Liposomes for Targeted Therapy of Ulcerative Colitis.

Journal: Journal of drug targeting
Published: June 24, 2026

Postbiotic extracellular vesicles: the next generation of natural products for ulcerative colitis.

Postbiotic extracellular vesicles: the next generation of natural products for ulcerative colitis.

Journal: Natural product research
Published: June 23, 2026

Correction to:NMI Promotes Pro-Inflammatory Macrophage Polarization and Exacerbates Ulcerative Colitis.

Correction to:NMI Promotes Pro-Inflammatory Macrophage Polarization and Exacerbates Ulcerative Colitis.

Journal: Inflammation
Published: June 23, 2026

Novel mouse models for perianal fistulizing Crohn's disease reveal therapeutic value of interferon-γ antagonists.

Novel mouse models for perianal fistulizing Crohn's disease reveal therapeutic value of interferon-γ antagonists.

Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026

A patent review of GPR84 receptor antagonists (2020-present).

A patent review of GPR84 receptor antagonists (2020-present).

Journal: Expert opinion on therapeutic patents
Published: June 22, 2026

Corrigendum to "Preparation of colon-targeted pellets loaded with filgotinib/berberine hydrochloride and Their application in ulcerative colitis therapy" [International Journal of Pharmaceutics: X 2025 (10) 100415].

Corrigendum to "Preparation of colon-targeted pellets loaded with filgotinib/berberine hydrochloride and Their application in ulcerative colitis therapy" [International Journal of Pharmaceutics: X 2025 (10) 100415].

Journal: International journal of pharmaceutics: X
Published: June 22, 2026

Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care

Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care

Journal: Zeitschrift fur Gastroenterologie
Published: June 22, 2026

Updated S3 guideline on ulcerative colitis

Updated S3 guideline on ulcerative colitis

Journal: Zeitschrift fur Gastroenterologie
Published: June 22, 2026

Sexual Distress Is Common in Long Term Follow-up After Pelvic Pouch for Ulcerative Colitis: A Cross-Sectional Study.

Sexual Distress Is Common in Long Term Follow-up After Pelvic Pouch for Ulcerative Colitis: A Cross-Sectional Study.

Journal: Diseases of the colon and rectum
Published: June 19, 2026

Histologic signatures as predictors of intestinal barrier impairment in inflammatory bowel disease: integration with endoscopic and molecular markers.

Histologic signatures as predictors of intestinal barrier impairment in inflammatory bowel disease: integration with endoscopic and molecular markers.

Journal: Journal of Crohn's & colitis
Published: June 18, 2026

Ultra-processed food intake and risk of inflammatory bowel disease in the adult population ‒ A systematic review and meta-analysis.

Ultra-processed food intake and risk of inflammatory bowel disease in the adult population ‒ A systematic review and meta-analysis.

Journal: Revista espanola de enfermedades digestivas
Published: June 18, 2026
Showing 1-12 of 57,791

Last Updated: 06/30/2026